Research and Markets has announced the addition of the "Sleep Apnea - Pipeline Review, H2 2016" report to their offering.
The report provides comprehensive information on the therapeutics under development for Sleep Apnea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Sleep Apnea and features dormant and discontinued projects.
According to 'Sleep Apnea - Pipeline Review, H2 2016'; Sleep Apnea pipeline therapeutics constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by Companies and remaining by the Universities Institutes.
Furthermore, the publisher says: Sleep Apnea is a potentially serious sleep disorder in which breathing repeatedly stops and starts. Symptoms include hypersomnia, morning headache, insomnia, dry mouth or sore throat when wake up. Risk factors include excess weight, family history, smoking and narrowed airway.
It also reviews of key players involved in therapeutic development for Sleep Apnea and features dormant and discontinued projects. Currently, The molecules developed by Companies in Phase III, Phase II and Preclinical stages are 1, 3 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/r3thqc/sleep_apnea
Related Topics: Respiratory Drugs
View source version on businesswire.com: http://www.businesswire.com/news/home/20160920005907/en/Business Wire
Last updated on: 20/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.